68Ga-BBN-IRDye800CW

N/A

Report date: 2025/11/20 16:01:01
NME

Base Information

Drug Name68Ga-BBN-IRDye800CW
Drug Alias Name68Ga-IRDye800CW-BBN68Ga-BBN-IRDye800CW
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5] 
Mechanisms of ActionPositron-emission tomography enhancersGastrin releasing peptide receptor antagonists
TargetsGastrin releasing peptide receptor
Therapy Area/IndicationsGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNational Institute For Biomedical Imaging And Bioengineering (Nibib)Chinese Academy Of SciencesPeking Union Medical College Hospital +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Tiantan Hospital, Capital Medical University
Inactive CompaniesNational Institute For Biomedical Imaging And Bioengineering (Nibib)Chinese Academy Of SciencesPeking Union Medical College Hospital
Active IndicationsGlioma
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A